Glenmark Pharmaceuticals and Hikma enter into partnership for commercialising RyaltrisT in the US EP News Bureau Feb 27, 2020 Glenmark will be responsible for the continued development and regulatory approval of RyaltrisTM by the US FDA, while Hikma will…
